Cnoline compound PI3K kinase inhibitor as well as preparation method and application thereof in pharmacy
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- FUDAN UNIV
- Publication Date
- 2021-06-01
- Estimated Expiration
- Not applicable · inactive patent
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of medicinal chemistry, in particular to the preparation and drug combination of cinnoline compounds or salts thereof, and the application to diseases, diseases or conditions related to PI3K kinases. Background technique
[0002] Phosphatidylinositol 3-kinase (PI3K) is an important signal transduction molecule in cells. PI3K participates in the regulation of cell proliferation, differentiation and apoptosis by phosphorylating the 3-hydroxyl group on the phosphatidylinositol ring. Physiological processes such as death. The abnormal activation of PI3K caused by the mutation of the upstream gene of PI3K (such as PIK3CA) or the inactivation mutation of its negative regulatory gene PTEN have been observed in cancer cells. It can be said that PI3K is closely related to the occurrence and development of various cancers and non-cancerous diseases (Vivanco, I.; Sawyers, C.L., Nat. Rev. Cancer 2002, 2, 489.). PI3K k...